Lima Stella Sala Soares, França Monique Sedlmaier, Godoi Camila Cristina Gonçalves, Martinho Glaucia Helena, de Jesus Lenize Adriana, Romanelli Roberta Maia de Castro, Clemente Wanessa Trindade
Hospital das Clínicas, Universidade Federal de Minas Gerais - HCUFMG, Belo Horizonte, MG, Brazil.
Rev Bras Hematol Hemoter. 2013;35(1):18-22. doi: 10.5581/1516-8484.20130009.
The aim of this study was to analyze the characteristics and infectious complications of neutropenic patients in a referral hospital.
A cross-sectional study was carried out between April and September 2008, which enrolled all neutropenic patients identified by daily blood counts in the Universidade Federal de Minas Gerais. Demographic data and information on infections were obtained from the Hospital Infection Control Committee. Statistical analysis was performed using the Statistical Package for Social Sciences.
One hundred and sixteen patients were followed up during 129 hospitalizations. The patients had a mean age of 48.7 years old. Sixty-four (55.2%) patients were male and 25 (21.6%) died during the follow-up. In 97 (75.2%) of the hospitalizations, patients had episodes of febrile neutropenia. Patients classified as low-risk had a mortality rate of 16.2% (n = 12) vs. 39.1% (n = 9) among high-risk patients (p-value = 0.02). The death rate of the patients who had been submitted to hematopoietic stem cell transplantation was 13.5% (n = 5) vs. 26.7% (n = 16) among patients not submitted to transplantation (p-value = 0.13). Of the 155 infections diagnosed, 45.5% were defined as clinically documented. The etiological agent most frequently isolated was Escherichia coli and the main topography reported was bloodstream infections. The most used antimicrobial agents were cefepime, vancomycin and fluconazole. Approximately 24% of patients evolved with impaired renal function during hospitalization.
Most reported infections in neutropenic patients were defined as clinically documented, which shows the importance of suspicion in patients without specific signs and symptoms for early diagnosis and the need for the classification of risk for timely interventions.
本研究旨在分析一家转诊医院中性粒细胞减少患者的特征及感染并发症。
于2008年4月至9月开展了一项横断面研究,纳入了米纳斯吉拉斯联邦大学通过每日血常规检查确定的所有中性粒细胞减少患者。人口统计学数据及感染信息来自医院感染控制委员会。使用社会科学统计软件包进行统计分析。
116例患者在129次住院期间接受了随访。患者的平均年龄为48.7岁。64例(55.2%)患者为男性,25例(21.6%)在随访期间死亡。在97次(75.2%)住院中,患者出现了发热性中性粒细胞减少发作。低风险患者的死亡率为16.2%(n = 12),而高风险患者为39.1%(n = 9)(p值 = 0.02)。接受造血干细胞移植的患者死亡率为13.5%(n = 5),未接受移植的患者为26.7%(n = 16)(p值 = 0.13)。在确诊的155例感染中,45.5%被定义为临床确诊。最常分离出的病原体是大肠杆菌,报告的主要感染部位是血流感染。最常用的抗菌药物是头孢吡肟、万古霉素和氟康唑。约24%的患者在住院期间出现肾功能损害。
中性粒细胞减少患者报告的大多数感染被定义为临床确诊,这表明对于无特定体征和症状的患者保持怀疑态度对于早期诊断很重要,且需要进行风险分类以便及时干预。